Observational studyAnnals of surgical oncology2026
PneumoScore: Risk Prediction Model for 90-Day Mortality After Lung Resection.
Observational study in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PneumoScore: A Novel Risk Prediction Model for 90-Day Mortality after Lung Resection.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundLung resection is the gold-standard treatment for early stage lung cancer, but remains associated with significant mortality, highlighting the need for accurate preoperative risk prediction. This study developed a novel model to predict 90-day mortality after lung cancer resection and compared its performance with well-established models.
methodsData were extracted from the Brazilian Lung Cancer Registry, a multicentric database including 2885 patients who underwent lung resection between 2002 and 2024. Records missing more than 15% of variables or any essential variable were excluded. The dataset was randomly divided into training (70%) and testing (30%) subsets. Candidate predictors were selected on the basis of clinical relevance and univariable analyses and multiple machine learning algorithms were evaluated. Final performance was assessed by area under receiver operating characteristic curve (AUROC), area under precision-recall curve (AUPR), Brier Score, Brier Skill Score (BSS), calibration slope, and intercept, using nonparametric bootstrapping to quantify variability.
resultsIn total, 2001 patients were included, of whom 88 (4.40%) died within 90 days post surgery. The best-performing model, PneumoScore, was a logistic regression incorporating age, sex, predicted postoperative FEV1%, ASA ≥ IV, coronary artery disease, cerebrovascular disease, congestive heart failure, pneumectomy, thoracotomy, and extended resection. PneumoScore achieved an AUROC of 0.84 (0.77-0.91), AUPR of 0.99 (0.98-1.00), Brier Score of 0.033 (0.022-0.045), BSS of 0.256 (0.180-0.332), intercept of 0.067 (-0.045, 0.179), and slope of 1.067 (0.912-1.222).
conclusionsPneumoScore demonstrated excellent performance for predicting 90-day mortality, a critical yet underexplored outcome in thoracic surgery, supporting its potential to enhance preoperative evaluation of patients with lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.